GetTopicDetailResponse(id=97371858432, topicName=VZV, introduction=VZV, content=null, image=null, comments=2, allHits=1260, url=https://h5.medsci.cn/topic?id=18584, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=93122, tagList=[TagDto(tagId=93122, tagName=VZV)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2208607, encodeId=2725220860ebd, content=<a href='/topic/show?id=99c864229d5' target=_blank style='color:#2F92EE;'>#水痘帶狀皰疹病毒#</a> <a href='/topic/show?id=97371858432' target=_blank style='color:#2F92EE;'>#VZV#</a>, objectTitle=水痘-帶狀皰疹病毒感染后再激活的機(jī)制及臨床表現(xiàn), objectType=article, longId=826286, objectId=a3c8826286ac, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240605/1717573432792_5579292.png, objectUrl=/article/show_article.do?id=a3c8826286ac, replyNumber=0, likeNumber=107, createdTime=2024-06-06, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a3c8826286ac, moduleTitle=水痘-帶狀皰疹病毒感染后再激活的機(jī)制及臨床表現(xiàn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a3c8826286ac)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1707508, encodeId=b39b1e07508af, content=<a href='/topic/show?id=97371858432' target=_blank style='color:#2F92EE;'>#VZV#</a>, objectTitle=CGH：37項(xiàng)臨床試驗(yàn)的數(shù)據(jù)分析表明，使用DAA治療HCV感染與VZV再激活風(fēng)險(xiǎn)增加之間無(wú)關(guān)聯(lián), objectType=article, longId=217087, objectId=67e521e08795, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67e521e08795, replyNumber=0, likeNumber=112, createdTime=2021-10-28, rootId=0, userName=124987a0m76(暫無(wú)昵稱), userId=6d7531423100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67e521e08795, moduleTitle=CGH：37項(xiàng)臨床試驗(yàn)的數(shù)據(jù)分析表明，使用DAA治療HCV感染與VZV再激活風(fēng)險(xiǎn)增加之間無(wú)關(guān)聯(lián), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=67e521e08795)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707507, encodeId=3ef61e075072d, content=<a href='/topic/show?id=97371858432' target=_blank style='color:#2F92EE;'>#VZV#</a>, objectTitle=Lancet: 自體造血干細(xì)胞移植者接種滅活VZV疫苗安全有效, objectType=article, longId=139301, objectId=52f01393013d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52f01393013d, replyNumber=0, likeNumber=123, createdTime=2019-04-17, rootId=0, userName=124987a0m76(暫無(wú)昵稱), userId=6d7531423100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52f01393013d, moduleTitle=Lancet: 自體造血干細(xì)胞移植者接種滅活VZV疫苗安全有效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=52f01393013d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
